Germany Cannabis

Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand

German Medical Association Urges Repeal Of Cannabis Law

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand

German Medical Association Urges Repeal Of Cannabis Law

Conference Of Justice Ministers Approves Proposal To Revise German Cannabis Law

Berlin's Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed

Conference Of Justice Ministers Approves Proposal To Revise German Cannabis Law

Berlin's Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed

Canopy Growth's German Subsidiary Teams Up With Portugal's Gro-Vida To Expand Medical Cannabis Supply

German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?

Germany Cannabis Recent News

European Leaders Meet In Berlin To Discuss Cannabis Policies

Tilray Joins German Cannabis Fiesta With First Locally Grown Strains

Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's expanding market...

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3

International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue from Germany grew 66% year-over-year, reaching CA$5.8 million ($4.1 million). "While the 66% growth we delivered in Germany, to reach $5.8M this quarter is a highlight, we spent the quarter focused on building a solid foundation for 2025," Oren Shuster, the company's CEO, said. "Our goal was to build a strong, consistent supply chain, along with a laser focus on how to improve the efficiency and accuracy of how we use our resources. I believe that the foundation we built this quarter will be the basis we will use to deliver in 2025."

Germany's Govt. Coalition Crisis, Is Cannabis Reform At Risk?

Germany's political crisis puts recent cannabis reforms at risk. Industry leaders weigh in on the potential impact of a conservative gov...

EXCLUSIVE: Persistence Pays Off For Only Cannabis Distributor In Bavaria's Developing Market

Drapalin Pharmaceuticals GmbH, Bavaria's sole licensed cannabis distributor, has transformed Germany's cannabis market with strategic growth

Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?

Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.

Frankfurt And Hannover Prepare For Cannabis Sales Study Amid Health Alarms Over Black Market Contamination

Banned Pesticides, Covid 19 Found In 80% Of Illegal Cannabis Samples From Germany And Europe

Cocaine Pizza Becomes Best-Seller At Düsseldorf Restaurant, Leading To Drug Ring Bust

Germany's Medical Marijuana Market Is Booming, Says Cannabis Producer Reporting Record Quarter

German Medical Marijuana Sales To Reach $1.09B By 2028, New Report

Is Germany Set To Become Next Cannabis Giant? 'We Tripled Within One Year,' Says Industry Insider

Germany's new cannabis law is causing growth in the market, with potential for more patients and adult-use cannabis.

How Germany's Cannabis Market Is Dominating Europe And Unlocking New Profit Opportunities

Experts from the Benzinga Cannabis Capital Conference examined the profitability and growth prospects across global marijuana markets.

Germany's Most Populous State Approves First Cannabis Cultivation Application

How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?

Spain's Ministry of Health revealed this week a draft royal decree for public consultation, outlining the suggested regulations for prescribing cannabis-based medications, reported Business of Cannabis. The news comes after years of negotiation and an increase in the legal production of medical cannabis, as earlier reported.

Conservative Politics Threaten Germany's Cannabis Legalization Plan: What's Going On?

Germany: Pillar 2 cannabis project faces political roadblocks and delays, risking its abandonment as conservatives push back...

Flora Growth Cannabis Expands European Presence With Strategic Supply Agreement For Medical Marijuana

Flora Growth Corp. announced a supply agreement with Blossom Genetics to bring Colombian medical cannabis to the German market.

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A.

20M Germans Could Benefit From Medical Marijuana But Most Struggle To Find Prescribing Doctors

Weed Smuggler Among Few Freed Under Germany's New Cannabis Law

Volkswagen Considers Hemp To Develop Sustainable Substitute For Imitation Leather

The world-renowned German automobile manufacturer Volkswagen (OTCPK:VWAGY) could soon be changing the way it produces its faux leather.

Stalled In Bureaucratic Limbo, This German City Struggles With Illegal Cannabis As Demand Surges

The slow response is largely due to complex bureaucratic requirements. Applicants must provide extensive documentation.

CBD Of Denver Q2 Revenue Jumps 37.4% YoY Amid German Market Expansion Plans

CBD of Denver, Inc. (OTC Pink: CBDD) today announced its unaudited financial results for the second quarter, a three-month period ended June 30, 2024. The Denver, Colorado-based company reported $1,002,240 in revenue for the period, representing a 37.4% increase from $729,453 in the same period in 2023. That's slightly lower than previously expected. The company said earlier this month it will post $1.03 million in revenue for the second quarter.